Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Clover Biopharmaceuticals Ltd. ( (HK:2197) ) is now available.
Clover Biopharmaceuticals Ltd. has announced its upcoming annual general meeting scheduled for June 19, 2025, in Chengdu, China. Key agenda items include the adoption of financial statements for 2024, re-election of directors, and the appointment of auditors. Additionally, the meeting will address resolutions to authorize the board to manage share capital, which may impact the company’s future financial strategies and shareholder value.
More about Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. The company focuses on developing innovative vaccines and biologic therapies, aiming to address unmet medical needs and improve global health outcomes.
Average Trading Volume: 1,449,292
Technical Sentiment Signal: Sell
Current Market Cap: HK$256.8M
For detailed information about 2197 stock, go to TipRanks’ Stock Analysis page.